Tessa Brabander
Papers
1
Total Citations
5
H-Index
1
About
Tessa Brabander is a clinical researcher whose work focuses on the intersection of advanced imaging and prostate cancer management, particularly in the post-surgical setting. Her key contributions center on evaluating the utility of Prostate Specific Membrane Antigen (PSMA) PET/CT in guiding treatment decisions for patients with biochemical recurrence after radical prostatectomy. In her most cited work, she investigated predictors of short-term oncologic outcomes in candidates for salvage radiation therapy, demonstrating that PSMA PET/CT can effectively identify patients without detectable metastases who may benefit from localized treatment. This research helps refine patient selection for salvage therapy, potentially sparing men from unnecessary systemic treatments. With her work accumulating citations in the urologic oncology literature, Brabander contributes to the growing evidence base supporting molecular imaging in prostate cancer care. Her findings offer practical guidance for clinicians navigating the challenging landscape of post-prostatectomy recurrence, highlighting the role of precision imaging in personalizing salvage treatment strategies.
Research Focus
Key Achievements
Top Papers
- 1